The Road to Cures Through Immunotherapy and Precision Medicine 

This activity provides learners with an overview of the latest advancements in biology and treatments for acute myeloid leukemia, aggressive lymphoma, and myeloma. The development and practical applications for CAR T-cell therapy in blood cancers is presented. A review of data from The Leukemia & Lymphoma Society patient registry on SARS-CoV-2 vaccination and antibody response in patients with blood cancer provides a glimpse of unmet needs in this vulnerable patient population.

Jointly provided by The Leukemia & Lymphoma Society and RMEI Medical Education, LLC.

Funding provided by The Leukemia & Lymphoma Society. No commercial support provided for this accredited continuing education activity.

     Leukemia Lymphoma Society logo           RMEI Logo

Series Courses